Companies / Larimar Therapeutics, Inc. / Activity
Activity — Larimar Therapeutics, Inc.
11 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q1 2026 as of | Marshall Wace, LLP 13F manager | New | Common stock | $4.20M | +933K | 933,464 0.90% of shares | low |
| Q1 2026 as of | Adage Capital Partners Gp, L.L.C. 13F manager | New | Common stock | $1.35M | +300K | 300,000 0.29% of shares | low |
| Q1 2026 as of | Hudson Bay Capital Management LP 13F manager | New | Common stock | $1.32M | +292K | 292,250 0.28% of shares | low |
| Q2 2026 as of | WINTON GROUP Ltd 13F manager | New | Common stock | $159.8K | +52K | 52,400 0.05% of shares | low |
| Q1 2026 as of | Prudential Financial Inc 13F manager | New | Common stock | $147.6K | +33K | 32,793 0.03% of shares | low |
| Q1 2026 as of | Mariner, LLC 13F manager | New | Common stock | $142.4K | +32K | 31,645 0.03% of shares | low |
| Q1 2023 as of | Barclays PLC 13F manager | New | Common stock | $128.2K | +28K | 28,293 0.03% of shares | low |
| Q2 2026 as of | Persistent Asset Partners Ltd 13F manager | New | Common stock | $114.0K | +37K | 37,374 0.04% of shares | low |
| Q1 2026 as of | Los Angeles Capital Management LLC 13F manager | New | Common stock | $81.1K | +18K | 18,022 0.02% of shares | low |
| Q1 2026 as of | Grantham, Mayo, Van Otterloo & Co. LLC 13F manager | New | Common stock | $58.8K | +13K | 13,065 0.01% of shares | low |
| Q2 2026 as of | Pinnacle Wealth Planning Services, Inc. 13F manager | New | Common stock | $25.2K | +8K | 8,264 <0.01% of shares | low |